Skip to main content

Table 5 Multiple linear regression analysis of ΔbaPWV with Δ value of other clinical parameters in the MET-DUL group

From: Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus

Variables

β

SE

t value

P value

95% CI

ΔNO

− 0.257

0.115

− 3.287

0.026

− 0.286 to − 0.903

ΔIL-6

0.186

0.109

2.832

0.043

1.093 to 2.886

ΔEPCs

− 0.373

0.147

− 5.206

0.002

− 0.305 to − 0.849

ΔEPA

− 0.296

0.151

− 3.749

0.018

− 0.261 to − 0.919

ΔEMA

− 0.215

0.132

− 2.985

0.037

− 0.174 to − 0.863

  1. MET-DUL metformin combined with dulaglutide treatment group, baPWV brachial–ankle pulse wave velocity, NO nitric oxide, IL-6 interleukin-6, EPCs, endothelial progenitor cells, EPA, endothelial progenitor cells proliferative ability, EMA, endothelial progenitor cells migration ability, ∆ the change value of various index before and after treatment
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840